Analysis of Safety, Risk Factors and Pretreatment Methods during Rush Hymenoptera Venom Immunotherapy

Publisher： Karger

E-ISSN： 1423-0097|147|3|241-245

ISSN： 1018-2438

Source： International Archives of Allergy and Immunology, Vol.147, Iss.3, 2008-07, pp. : 241-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk Assessment of Hymenoptera Re-Sting Frequency: Implications for Decision-Making in Venom Immunotherapy

By  

International Archives of Allergy and Immunology, Vol. 160, Iss. 1, 2012-09 ,pp. : 86-92

Karger

Access to resources Recommend Favorite

Immunological and clinical factors associated with adverse systemic reactions during the build‐up phase of honeybee venom immunotherapy

By  

CLINICAL & EXPERIMENTAL ALLERGY, Vol. 45, Iss. 10, 2015-10 ,pp. : 1579-1589

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immunological and clinical factors associated with adverse systemic reactions during the build‐up phase of honeybee venom immunotherapy

By  

CLINICAL & EXPERIMENTAL ALLERGY, Vol. 954-7894, Iss. 10, 2015-10 ,pp. : 1579-1589

John Wiley & Sons Inc

Access to resources Recommend Favorite

Wasp Venom Rush Immunotherapy Induces Transient Downregulation of B Cell Surface Molecule Expression

By  

International Archives of Allergy and Immunology, Vol. 127, Iss. 3, 2002-04 ,pp. : 226-233

Karger

Access to resources Recommend Favorite

Three Days Rush Venom Immunotherapy in Bee Allergy: Safe, Inexpensive and Instantaneously Effective

By  

International Archives of Allergy and Immunology, Vol. 156, Iss. 1, 2011-03 ,pp. : 90-98

Karger

Access to resources Recommend Favorite